Mark Bonyhadi
Direttore/Membro del Consiglio presso TC BIOPHARM (HOLDINGS) PLC
Patrimonio netto: - $ in data 30/11/2023
Posizioni attive di Mark Bonyhadi
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| TC BIOPHARM (HOLDINGS) PLC | Direttore/Membro del Consiglio | 22/02/2022 | - |
| Independent Dir/Board Member | 22/02/2022 | - |
Storia della carriera di Mark Bonyhadi
Precedenti posizioni note di Mark Bonyhadi
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Qiming US Ventures Management, LLC
 Qiming US Ventures Management, LLC Investment ManagersFinance Qiming US Ventures Management LLC (Qiming Venture Partners) is a venture capital subsidiary of Qiming Venture Partners Ltd founded in 2017 by Mark D. McDade and Gary Edward Rieschel. The firm is headquartered in Cambridge, Massachusetts. | Consulente / Consigliere | 01/12/2018 | 31/12/2022 |
| Investitore di Private Equity | 01/12/2018 | 31/12/2022 | |
Systemix, Inc.
 Systemix, Inc. Medical/Nursing ServicesHealth Services Systemix, Inc. develops cell-based gene therapies for diseases. The company is based in Palo Alto, CA. The company was founded by Irving L. Weissman, Leroy E. Hood. Systemix was acquired by Novartis AG on February 14, 1997 for $75.90 million. | Direttore Tecnico/Scientifico/R&S | - | 12/10/2021 |
| JUNO THERAPEUTICS INC | Corporate Officer/Principal | 01/01/2013 | 01/01/2018 |
Life Technologies Ltd.
 Life Technologies Ltd. BiotechnologyHealth Technology Life Technologies Ltd. engages in scientific and medical activities. The company was founded on May 13, 1983 and is headquartered in Paisley, the United Kingdom. | Corporate Officer/Principal | 01/01/2006 | 01/01/2013 |
| Xcyte Therapies, Inc. | Direttore Tecnico/Scientifico/R&S | 01/01/1997 | 30/03/2006 |
American Society of Gene & Cell Therapy
 American Society of Gene & Cell Therapy Miscellaneous Commercial ServicesCommercial Services The American Society of Gene & Cell Therapy is a medical and professional organization that represents researchers and scientists devoted to the discovery of gene and cell therapies. The American company was founded by Mark A. Kay. | Presidente | - | - |
Formazione di Mark Bonyhadi
| The Reed Institute | Undergraduate Degree |
| University of California, Berkeley | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 8 |
| Regno Unito | 3 |
Posizioni
| Chief Tech/Sci/R&D Officer | 2 |
| Corporate Officer/Principal | 2 |
| Undergraduate Degree | 1 |
Settori
| Health Technology | 5 |
| Consumer Services | 3 |
| Finance | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| TC BIOPHARM (HOLDINGS) PLC | Health Technology |
| Aziende private | 6 |
|---|---|
| Xcyte Therapies, Inc. | Health Technology |
Juno Therapeutics, Inc.
 Juno Therapeutics, Inc. BiotechnologyHealth Technology Juno Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of innovative cellular immunotherapy for the treatment of cancer. It offers platforms which includes chimeric antigen receptors and T-cell receptors. The company was founded by Hans Edgar Bishop, Lawrence Corey, Richard D. Klausner, Stan Riddell, Isabelle Riviere, and Robert Taylor Nelsen on August 5, 2013 and is headquartered in Seattle, WA. | Health Technology |
Life Technologies Ltd.
Life Technologies Ltd. BiotechnologyHealth Technology Life Technologies Ltd. engages in scientific and medical activities. The company was founded on May 13, 1983 and is headquartered in Paisley, the United Kingdom. | Health Technology |
Qiming US Ventures Management, LLC
Qiming US Ventures Management, LLC Investment ManagersFinance Qiming US Ventures Management LLC (Qiming Venture Partners) is a venture capital subsidiary of Qiming Venture Partners Ltd founded in 2017 by Mark D. McDade and Gary Edward Rieschel. The firm is headquartered in Cambridge, Massachusetts. | Finance |
Systemix, Inc.
Systemix, Inc. Medical/Nursing ServicesHealth Services Systemix, Inc. develops cell-based gene therapies for diseases. The company is based in Palo Alto, CA. The company was founded by Irving L. Weissman, Leroy E. Hood. Systemix was acquired by Novartis AG on February 14, 1997 for $75.90 million. | Health Services |
American Society of Gene & Cell Therapy
American Society of Gene & Cell Therapy Miscellaneous Commercial ServicesCommercial Services The American Society of Gene & Cell Therapy is a medical and professional organization that represents researchers and scientists devoted to the discovery of gene and cell therapies. The American company was founded by Mark A. Kay. | Commercial Services |
- Borsa valori
- Insiders
- Mark Bonyhadi
- Esperienza
